AligosListed
aligos.combiotech_life_sciences
Aligos Therapeutics is a clinical-stage biotechnology company focused on developing best-in-class therapies for liver and viral diseases, particularly chronic hepatitis B virus in…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Aligos Therapeutics is a clinical-stage biotechnology company focused on developing best-in-class therapies for liver and viral diseases, particularly chronic hepatitis B virus in…
Bonum Therapeutics uses a novel, antibody-based mechanism to create regulated and targeted, highly active, and less toxic medicines, focusing on antibody-controlled cytokine-based…
Civi Biopharma is a US-based, privately held biopharmaceutical company focused on creating novel therapies against cardiovascular and metabolic diseases. The company has developed…
COUR Pharmaceuticals is developing targeted therapies that re-establish calm within the immune system and help restore the health of people suffering from autoimmune diseases. The…
DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of diabetic pat…
Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics aimed at addressing unmet medical needs…
Enthera Pharmaceuticals develops first-in-class biologics for underserved autoimmune conditions, focusing on Type 1 Diabetes and Inflammatory Bowel Disease. Their therapeutic appr…
Entrada Therapeutics is focused on developing intracellular therapeutics to treat devastating diseases, particularly targeting rare diseases like Duchenne muscular dystrophy and m…
EpiBiologics is focused on advancing bispecific antibodies designed to selectively degrade disease-causing extracellular proteins, leveraging their EpiTAC platform to create tissu…
Forcefield Therapeutics is a pioneer of best-in-class therapeutics aimed at preserving heart function by protecting cardiomyocytes, particularly following myocardial infarction (h…
Freenome is setting a new pace for early cancer detection by combining the latest in science and artificial intelligence, with the ease of a standard blood draw.
GlycoEra is focused on developing biologics to selectively target and degrade specific circulating proteins, particularly autoantibodies, that drive autoimmune diseases. Their inn…
Kumquat Biosciences is focused on innovating life-changing medicines for cancer patients, utilizing expertise in the KRAS pathway to develop targeted and immuno-oncology therapies.
Merge Therapeutics is a pioneering biotech company developing multispecific antibodies designed to fundamentally shift the treatment paradigm for autoimmune diseases. Their goal i…
Minoryx Therapeutics is a clinical stage biotech company focused on the discovery and development of innovative treatments for orphan CNS diseases, particularly X-linked Adrenoleu…
Mironid is a biopharmaceutical company developing novel small-molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney…
Mission Therapeutics is a drug development company focused on treating kidney disease, neurodegenerative diseases, and rare mitochondrial diseases. The company targets the ubiquit…
NMD Pharma discovers and develops novel therapeutics for neuromuscular diseases, focusing on small molecule inhibitors of skeletal muscle-specific ClC-1 ion channels. Their lead c…
Noema Pharma is a clinical-stage biotech developing a late-stage portfolio of oral small molecule therapeutics with well-characterized mechanisms and unique features aimed at deli…
Receptive Bio is a biotechnology company focused on novel next-generation blood-brain barrier shuttles targeting novel receptors to enable selective and effective delivery of ther…
Developer of novel therapies intended to cure orphan diseases.
Sarepta Therapeutics is a biotechnology company focused on developing innovative RNA-targeted therapeutics to treat rare diseases, particularly genetic disorders such as Duchenne…
SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. The company utilizes its proprietary Pr…
Tempest Therapeutics is a clinical-stage biotechnology company focused on pioneering a pipeline of next generation in vivo CAR-T cell therapies for autoimmune and oncology indicat…
Vivet Therapeutics is a clinical-stage emerging biotechnology company developing novel gene therapy treatments for rare, inherited metabolic diseases.